Fig. 1
a, b Survival according to the risk categories as defined by the sorafenib model. Kaplan–Meier survival curves and the corresponding risk table for (a) training and (b) validation set
Fig. 1 | British Journal of Cancer
a, b Survival according to the risk categories as defined by the sorafenib model. Kaplan–Meier survival curves and the corresponding risk table for (a) training and (b) validation set
